June 2022
The SAMRC has welcomed the recent announcement made by the Global Antibiotic Research and Development Partnership (GARDP) and Shionogi & Co., Ltd. (Shionogi) about the execution of a license and technology transfer agreement with the Clinton Health Access Initiative (CHAI). The announcement also includes a collaboration agreement that aims to significantly transform the landscape of access to antibiotics in 135 countries around the world.